Form 13-F position report

GLOBUS MED INC

Reported by Hyperion Capital Advisors LP

GMED CUSIP 379577208 Manager CIK 0001794499

Reported 71,476 shares, down 69,373 (49.3%) from the prior quarter.

Reported value -53.5%; share count -49.3% vs. the prior quarter.

Reduced
% of reported 13F value 2.55% This manager · Q2 2026
Shares 71,476 Quarter-end amount reported
Reported value $5,647,319 Fair value at quarter end
Consecutive quarters held 3 Through Q2 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-12-31 12822085
2026-03-31 12135550
2026-06-30 5647319

Quarterly position history

How this manager's reported quarter-end position changed over time.

3 quarters
Quarterly reported position history for GLOBUS MED INC held by Hyperion Capital Advisors LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 71,476 -69,373 (-49.3%) 2.55% $5,647,319 2026-08-14
Q1 2026 Reduced 140,849 -6,008 (-4.1%) 5.84% $12,135,550 2026-05-15
Q4 2025 New 146,857 +146,857 (0.0%) 6.28% $12,822,085 2026-02-13

Who else reported the position

690 managers reported GLOBUS MED INC for Q2 2026.

Managers reporting GLOBUS MED INC in Q2 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 10,806,724 +309,310 0.01% $853,839,261 8 qtrs
Jupiter Topco LLC New 8,200,423 +8,200,423 0.26% $647,930,962 1 qtr
VANGUARD CAPITAL MANAGEMENT LLC Added 5,107,532 +74,800 < 0.01% $403,546,103 2 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 4,994,385 +114,926 0.02% $394,606,359 2 qtrs
Invesco Ltd Reduced 4,309,771 -6,883 0.03% $340,515,006 53 qtrs
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC New 4,279,730 +4,279,730 1.05% $338,141,467 1 qtr
STATE STREET CORPORATION Added 3,714,029 +123,657 < 0.01% $293,540,630 53 qtrs
Sculptor Capital LP Reduced 3,000,000 -58,000 1.93% $237,030,000 11 qtrs
JPMorgan Chase & Co Added 2,743,850 +148,542 0.01% $230,761,440 48 qtrs
ALLIANCEBERNSTEIN L P Added 2,380,344 +629,512 0.07% $205,090,439 53 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2026
Filed
August 14, 2026
Filing type
13F-HR
Position type
CL A

Voting authority reported

Sole
71,476
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.